Gara Jalqabaatti › Saree (Gosoota Hunda) › Ohio › Columbus
Qorannoo klinikaalii Saree (Gosoota Hunda) Columbus, OH keessatti
Qorannoo 38 Saree (Gosoota Hunda) f Columbus fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
Beginning Radiation Immediately With GammaTile at GBM Excision Versus Standard of Care
Namoota walitti qabaa jiraSadarkaa 3
- The Ohio State University, Columbus
A Study of Mocertatug Rezetecan in Combination With Anti-cancer Therapies for Advanced Solid Tumors (BEHOLD-2)
Namoota walitti qabaa jiraSadarkaa 1/2
- GSK Investigational Site, Columbus
Met Non Small Cell Cancer Registry (MOMENT)
Namoota walitti qabaa jiraQorannoo ilaalaa
- The Ohio State University Wexner Medical Center, Columbus
uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
Namoota walitti qabaa jiraQorannoo ilaalaa
- Ohio State University, Columbus
A Study of MK-5684 in People With Certain Solid Tumors (MK-5684-015/OMAHA-015)
Namoota walitti qabaa jiraSadarkaa 2
- The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive C ( Site 0008), Columbus
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
Namoota walitti qabaa jiraQorannoo ilaalaa
- The Ohio State University Comprehensive Cancer Center, Columbus
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
Namoota walitti qabaa jiraSadarkaa 3
- Quetzal Site 8, Columbus
Pan Tumor Rollover Study
Namoota walitti qabaa jiraSadarkaa 2
- The Ohio University, Columbus
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Namoota walitti qabaa jiraSadarkaa 2/3
- Ohio State University Comprehensive Cancer Center (OSUCCC) - The James Cancer Hospital and Solove Research Institute, Columbus
Collection of Tissue Samples for Cancer Research
Namoota walitti qabaa jiraQorannoo ilaalaa
- Ohio State University, Columbus
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
Namoota walitti qabaa jiraSadarkaa 2
- The Ohio State University, Department of Psychiatry, Columbus
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Namoota walitti qabaa jiraSadarkaa 3
- The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer -T, Columbus
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
Namoota walitti qabaa jiraQorannoo ilaalaa
- Ohio State University, Columbus
Project: Every Child for Younger Patients With Cancer
Namoota walitti qabaa jiraQorannoo ilaalaa
- Nationwide Children's Hospital, Columbus
- Ohio State University Comprehensive Cancer Center, Columbus
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
- The Ohio State University Comprehensive Cancer Center, Columbus
A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
Namoota walitti qabaa jiraSadarkaa 2
- Nationwide Children's Hosp, Columbus
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Namoota walitti qabaa jiraSadarkaa 3
- Ohio State University Comprehensive Cancer Center, Columbus
- Columbus Oncology and Hematology Associates Inc, Columbus
- Riverside Methodist Hospital, Columbus
- fi 8 dabalataa
Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG).
Namoota walitti qabaa jiraSadarkaa 2
- Nationwide Children's Hospital, Columbus
The MedMemos Study: Promoting Adherence to Medications in Pediatric Bone Marrow Transplant Patients
Namoota walitti qabaa jira
- Nationwide Children's Hospital, Columbus
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations
Namoota walitti qabaa jiraSadarkaa 1/2
- The Ohio State University /ID# 271336, Columbus
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
Namoota walitti qabaa jiraSadarkaa 1
- The Ohio State University Comprehensive Cancer Center, Columbus
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
- Stefanie Spielman Comprehensive Breast Center, Columbus
Childhood Cancer Survivor Study
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
- Nationwide Children's Hospital, Columbus
Tempus Small Cell Lung Cancer Observational Study (Sculptor)
Namoota walitti qabaa jiraQorannoo ilaalaa
- Ohio State University, Columbus
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
Namoota walitti qabaa jiraSadarkaa 1/2
- The Ohio State University Comprehensive Cancer Center, Columbus
Isa-Rd for Frail and/or Much Older Patients With Newly Diagnosed Multiple Myeloma
Namoota walitti qabaa jiraSadarkaa 2
- The Ohio State University Comprehensive Cancer Center, Columbus
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
Namoota walitti qabaa jiraSadarkaa 1/2
- The Ohio State University Wexner Medical Center, Columbus
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
- Ohio State University Wexner Medical Center Gynecologic Oncology at Mill Run, Columbus
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Namoota walitti qabaa jiraSadarkaa 2
- The Ohio State University, Stefanie Spielman Comprehensive Breast Center, Columbus
Precision Cancer Medicine for Advanced Cancer Through High-throughput Sequencing
Namoota walitti qabaa jiraQorannoo ilaalaa
- Ohio State University Wexner Medical Center, Columbus
Re-Engaging AYA Survivors in Cancer-Related Healthcare
Namoota walitti qabaa jira
- Nationwide Children's Hospital, Columbus
Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)
Namoota walitti qabaa jiraSadarkaa 2
- The Ohio State University /ID# 230439, Columbus
GEMINI-NSCLC: NSCLC Biomarker Study
Namoota walitti qabaa jiraQorannoo ilaalaa
- Ohio State University, Columbus
- OhioHealth Reseach Institute, Columbus
Preparing for Life and Academics for Young Childhood Cancer Survivors
Namoota walitti qabaa jira
- Nationwide Children's Hospital, Columbus
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Namoota walitti qabaa jiraQorannoo ilaalaa
- Massive Bio SYNERGY-AI site, Columbus
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
Namoota walitti qabaa jiraSadarkaa 1/2
- The Ohio State University, Columbus
Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays
Namoota walitti qabaa jiraQorannoo ilaalaa
- Ohio State University, Columbus
- OhioHealth Research Institute, Columbus
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Namoota walitti qabaa jira
- Ohio State University Comprehensive Cancer Center, Columbus
Qorannoo Saree (Gosoota Hunda) magaalota biroo keessatti
- Houston, TXQorannoo 121
- New York City, NYQorannoo 109
- Boston, MAQorannoo 85
- Los Angeles, CAQorannoo 74
- Nashville, TNQorannoo 65
- Philadelphia, PAQorannoo 59
- Washington, DCQorannoo 58
- Durham, NCQorannoo 58
- Chicago, ILQorannoo 51
- Atlanta, GAQorannoo 49
- Seattle, WAQorannoo 49
- Arlington, VAQorannoo 48
Qorannoo biroo Columbus keessatti
- Kansara Qara'a Non-Small CellQorannoo 57
- Saree OljooQorannoo 40
- Kansarii OvariiQorannoo 39
- Dhibee QaraQorannoo 37
- Leukemia Myeloidii HamaaQorannoo 35
- Luukemiya Limfoositiikii KeessummaaQorannoo 28
- Kansara MetastatikiiQorannoo 27
- Kansa EndometiriyaaliiQorannoo 25
- Kansarii ProstateQorannoo 24
- Myeloma Baay’eeQorannoo 24
- Kansarii ColorectalQorannoo 24
- MelanomaQorannoo 21
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.